Literature DB >> 21203975

A novel non-radioactive assay for HIV-RT (RdDp) based on pyrosequencing for high-throughput drug screening.

Chang Zhang1, Yang Wu, Yuna Sun, Chuan Hong, Kehui Xiang, Yu Guo, Mark Bartlam, Zhiyong Lou.   

Abstract

Current in vitro assays for the activity of HIV-RT (reverse transcriptase) require radio-labeled or chemically modified nucleotides to detect reaction products. However, these assays are inherently end-point measurements and labor intensive. Here we describe a novel non-radioactive assay based on the principle of pyrosequencing coupled-enzyme system to monitor the activity of HIV-RT by indirectly measuring the release of pyrophosphate (PP(i)), which is generated during nascent strand synthesis. The results show that our assay could monitor HIV-RT activity with high sensitivity and is suitable for rapid high-throughput drug screening targeting anti-HIV therapies due to its high speed and convenience. Moreover, this assay can be used to measure primase activity in an easy and sensitive manner, which suggests that this novel approach could be wildly used to analyze the activity of PP(i)-generated and ATP-free enzyme reactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21203975      PMCID: PMC4875084          DOI: 10.1007/s13238-010-0031-0

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  22 in total

1.  A highly sensitive chemiluminescent reverse transcriptase assay for human immunodeficiency virus.

Authors:  Fumitomo Odawara; Hideki Abe; Takehiro Kohno; Youko Nagai-Fujii; Kenji Arai; Shigeyuki Imamura; Hideo Misaki; Hiroshi Azuma; Kenji Ikebuchi; Hisami Ikeda; Sharad Mohan; Kouichi Sano
Journal:  J Virol Methods       Date:  2002-10       Impact factor: 2.014

Review 2.  Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases.

Authors:  Stefan G Sarafianos; Kalyan Das; Stephen H Hughes; Eddy Arnold
Journal:  Curr Opin Struct Biol       Date:  2004-12       Impact factor: 6.809

3.  Reverse transcriptase inhibition as prescreen for potential antiviral bioactives.

Authors:  M D Antoun; Y R Ríos; N T Mendoza; G Proctor
Journal:  P R Health Sci J       Date:  1994-03       Impact factor: 0.705

4.  A sequencing method based on real-time pyrophosphate.

Authors:  M Ronaghi; M Uhlén; P Nyrén
Journal:  Science       Date:  1998-07-17       Impact factor: 47.728

5.  Crystallization of human immunodeficiency virus type 1 reverse transcriptase with and without nucleic acid substrates, inhibitors, and an antibody Fab fragment.

Authors:  A D Clark; A Jacobo-Molina; P Clark; S H Hughes; E Arnold
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

6.  A sensitive non-isotopic assay specific for HIV-1 associated reverse transcriptase.

Authors:  T Porstmann; K Meissner; R Glaser; S H Döpel; G Sydow
Journal:  J Virol Methods       Date:  1991 Feb-Mar       Impact factor: 2.014

7.  Quantitative detection of RT activity by PERT assay: feasibility and limits to a standardized screening assay for human vaccines.

Authors:  M André; S Morgeaux; F Fuchs
Journal:  Biologicals       Date:  2000-06       Impact factor: 1.856

8.  Exploiting polymerase promiscuity: A simple colorimetric RNA polymerase assay.

Authors:  W Vassiliou; J B Epp; B B Wang; A M Del Vecchio; T Widlanski; C C Kao
Journal:  Virology       Date:  2000-09-01       Impact factor: 3.616

9.  Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors.

Authors:  A Hizi; R Tal; M Shaharabany; M J Currens; M R Boyd; S H Hughes; J B McMahon
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

10.  Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.

Authors:  A Jacobo-Molina; J Ding; R G Nanni; A D Clark; X Lu; C Tantillo; R L Williams; G Kamer; A L Ferris; P Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

View more
  2 in total

1.  SYBR Green II Dye-Based Real-Time Assay for Measuring Inhibitor Activity Against HIV-1 Reverse Transcriptase.

Authors:  Chakradhar Kokkula; Navaneethan Palanisamy; Malin Ericstam; Johan Lennerstrand
Journal:  Mol Biotechnol       Date:  2016-10       Impact factor: 2.695

2.  Quantitative Evaluation of Very Low Levels of HIV-1 Reverse Transcriptase by a Novel Highly Sensitive RT-qPCR Assay.

Authors:  Francesca Marino-Merlo; Valeria Stefanizzi; Agnese Ragno; Lucia Piredda; Sandro Grelli; Beatrice Macchi; Antonio Mastino
Journal:  Life (Basel)       Date:  2022-07-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.